Back to Search
Start Over
Comparison of Selected Older and Younger Patients Regarding Optimal Surgical Treatment of Colorectal Cancer: A Prospective Cohort Study.
- Source :
-
Cancer diagnosis & prognosis [Cancer Diagn Progn] 2023 Jul 03; Vol. 3 (4), pp. 504-513. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Background/aim: Current evidence regarding the optimal management of older colorectal cancer patients, is conflicting. Functional deficits impact long-term survival prognosis, while frailty often results to optimal treatment postponement. Thus, the characteristics of this subgroup combined with treatment deviations further perplex optimal oncological management. The study aim was to compare survival and optimal surgery rates between older and younger colorectal cancer patients.<br />Patients and Methods: This study was designed as a prospective cohort. All adult (³18 years) colorectal cancer patients operated, during the 2016-2020 period, in the Department of Surgery, University Hospital of Larissa, were considered as eligible. The primary endpoint of the study was the difference in terms of the overall survival between older (>70 year) and younger (<70 years) colorectal cancer patients.<br />Results: Overall, 166 patients (60 younger and 106 older) were enrolled. Although the older subgroup displayed a higher rate (p=0.007) of ASA II and ASA III patients, mean CCI scores were comparable (p=0.384). The two subgroups were similar in terms of performed operations (p=0.140). No delay in surgery was noted. Most operations were performed using an open approach (open: 57.8% vs. laparoscopic: 42.2%), under an elective status (elective: 91% vs. emergency: 1.8%). There was no difference in terms of overall complications rate (p=0.859). Overall survival was similar (p=0.227) between the older and younger subgroups (25.68 vs. 28.48 months).<br />Conclusion: Older operated patients did not differ from their younger counterparts with regard to their overall survival. Due to several study limitations, further trials are required to confirm these findings.<br />Competing Interests: The Authors declare that they have no conflicts of interest.<br /> (Copyright 2023, International Institute of Anticancer Research.)
Details
- Language :
- English
- ISSN :
- 2732-7787
- Volume :
- 3
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cancer diagnosis & prognosis
- Publication Type :
- Academic Journal
- Accession number :
- 37405213
- Full Text :
- https://doi.org/10.21873/cdp.10247